Ganciclovir to Prevent Reactivation of Cytomegalovirus in Patients With Acute Respiratory Failure and Sepsis
Clinical trial NCT04706507 · TERMINATED
Trial details
- NCT number
- NCT04706507
- Sponsor
- Fred Hutchinson Cancer Center
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-29
- Primary completion
- 2024-10-25
- Enrollment
- 205
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.